CALC

CalciMedica Inc

1.98

Sep 11 • 3:57 PM ET -0.14 (-6.60%)

2.02

Aftermarket • 7:30 PM ET +0.04 (1.97%)

Healthcare Biotechnology USA Nano NASD

Peers: BCDA BIVI CVM NEUP AIM APRE KAPA KPRX GOVX JAGX

| Held by: VXF

Scroll to Statements

Index	-
Market Cap	13.52M
Enterprise Value	4.10M
Income	-21.24M
Sales	0.00M
Book/sh	0.90
Cash/sh	2.73
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	16
IPO	Sep 25, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	2.21
P/C	0.73
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.58
Current Ratio	5.58
Debt/Eq	1.67
LT Debt/Eq	1.67
Option/Short	No / Yes

EPS (ttm)	-6.79
EPS next Y	-5.30
EPS next Q	-1.27
EPS this Y	69.37%
EPS next Y	-75.69%
EPS next 5Y	36.90%
EPS past 3/5Y	89.18% 38.92%
Sales past 3/5Y	- -
EPS Y/Y TTM	15.38%
Sales Y/Y TTM	-
EPS Q/Q	-12.66%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	-57.89% -

Insider Own	39.39%
Insider Trans	10.20%
Inst Own	34.43%
Inst Trans	-
ROA	-110.10%
ROE	-365.70%
ROIC	-144.36%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-22.47%
SMA50	-41.07%
SMA200	-76.22%
Trades

Shs Outstand	6.15M
Shs Float	4.14M
Short Float	3.08%
Short Ratio	0.47
Short Interest	0.13M
52W High	36.00 -94.50%
52W Low	1.91 3.66%
Volatility	11.38% 10.19%
ATR (14)	0.29
RSI (14)	34.14
Beta	0.70
Rel Volume	0.08
Avg Volume	273.06K
Volume	23,158

Perf Week	-10.00%
Perf Month	-36.12%
Perf Quarter	-55.58%
Perf Half Y	-45.45%
Perf YTD	-93.99%
Perf Year	-88.45%
Perf 3Y	-87.68%
Perf 5Y	-99.28%
Perf 10Y	-
Recom	1.67
Target Price	37.50
Prev Close	2.12
Price	1.98
Change %	-6.60%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-20-26	Initiated	Guggenheim	Buy	$9
Jan-29-26	Downgrade	H.C. Wainwright	Buy → Neutral

Sep-08-26 07:00AM	CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference (GlobeNewswire) -6.91%
Aug-27-26 09:00AM	CalciMedica Announces One-for-Five Reverse Stock Split (GlobeNewswire) -20.00%
Aug-11-26 10:11AM	CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss (InvestorsHub)
07:00AM	CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
Jul-29-26 07:00AM	CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints (PR Newswire)
07:01AM	Loading…
Jun-24-26 07:01AM	CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program (PR Newswire) -25.64%
07:00AM	CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data (PR Newswire)
May-12-26 07:00AM	CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) +6.63%
Mar-03-26 07:00AM	CalciMedica Reports 2025 Financial Results and Provides Clinical Updates (PR Newswire) +14.44%
Jan-29-26 07:24AM	CalciMedicas stock drops 75% on acute kidney injury trial termination (Clinical Trials Arena) -18.40%
Jan-28-26 11:48AM	CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis (Benzinga) -75.59%
07:00AM	CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation (PR Newswire)
Nov-12-25 07:01AM	CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
07:00AM	CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension (PR Newswire)
Nov-10-25 07:00AM	CalciMedica Presents Data from Preclinical Study of Auxora in an Animal Model of AKI at ASN Kidney Week 2025 (PR Newswire)
07:00AM	Loading…
Oct-14-25 07:00AM	CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora (PR Newswire)
Sep-02-25 07:00AM	CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference (PR Newswire) +14.81%
Aug-19-25 02:42PM	Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks (MarketBeat) -5.54%
Aug-12-25 07:00AM	CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -10.14%
Jul-08-25 07:00AM	CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference (PR Newswire)
Jun-25-25 07:00AM	CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora in AKI with Respiratory Failure (PR Newswire)
Jun-12-25 07:00AM	CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting (PR Newswire)
May-14-25 07:00AM	CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Apr-17-25 07:00AM	CalciMedica Announces Presentations at Upcoming Medical Meetings (PR Newswire)
Apr-02-25 12:00PM	CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade (Zacks) -5.13%
Apr-01-25 07:00AM	CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference (PR Newswire)
Mar-27-25 07:00AM	CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Mar-05-25 07:00AM	CalciMedica Secures Credit Facility for Up to $32.5 Million (PR Newswire) -6.17%
Mar-04-25 07:00AM	CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference (PR Newswire)
Feb-19-25 07:00AM	CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference (PR Newswire)
04:05PM	Loading…
Feb-03-25 04:05PM	CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference (PR Newswire)
Jan-14-25 07:00AM	CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors (PR Newswire)
Nov-21-24 08:00AM	CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference (PR Newswire)
Nov-20-24 04:05PM	CalciMedica Announces Presentations at Upcoming Medical Meetings (PR Newswire)
Nov-13-24 07:00AM	CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Nov-07-24 07:00AM	CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer (PR Newswire)
Oct-30-24 10:11PM	CalciMedica Announces Pricing of Public Offering of Common Stock (PR Newswire) +22.14% -22.92%
04:50PM	CalciMedica Announces Proposed Public Offering of Common Stock (PR Newswire)
07:00AM	CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting (PR Newswire)
Oct-28-24 04:05PM	CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire)
Oct-16-24 08:00AM	CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting (PR Newswire)
Sep-03-24 08:00AM	CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire) +7.67%
Aug-12-24 04:10PM	CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Jul-09-24 07:30AM	CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury (AKI) (PR Newswire)
Jul-08-24 08:00AM	CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences (PR Newswire)
Jul-01-24 08:00AM	CalciMedica Set to Join Russell Microcap Index (PR Newswire) +7.32%
Jun-27-24 08:00AM	CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -32.40%
07:06AM	CalciMedica's calcium channel inhibitor helps subgroup of pancreatitis patients eat solids sooner (FierceBiotech.com)
Jun-26-24 04:05PM	CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -10.04%
May-28-24 07:53AM	CALC Stock Earnings: CalciMedica Beats EPS for Q1 2024 (InvestorPlace)
May-21-24 09:48AM	3 Massively Undervalued 10-Bagger Stocks to Buy (InvestorPlace)
May-13-24 04:05PM	CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -7.14% +6.73%
May-07-24 08:00AM	CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 (PR Newswire)
Apr-24-24 08:00AM	CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (PR Newswire) +19.61%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-28-24 11:53AM	CALC Stock Earnings: CalciMedica Reported Results for Q4 2023 (InvestorPlace)
07:00AM	CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Mar-13-24 08:00AM	CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-28-24 06:57PM	CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-13-24 08:00AM	CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury (PR Newswire) -8.21%
Feb-07-24 04:05PM	CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) +6.92% -9.99%
Jan-22-24 08:00AM	CalciMedica Announces Private Placement of up to Approximately $55 Million (PR Newswire) +7.09%
Dec-11-23 07:30AM	CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition (PR Newswire) -13.88%
Nov-09-23 07:00AM	CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -12.74%
Nov-02-23 09:15AM	CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition (PR Newswire) +10.23%
Sep-06-23 07:30AM	CalciMedica Announces Upcoming Presentations and Events in September (PR Newswire) +5.18%
Aug-31-23 07:30AM	CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 (PR Newswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 04:05PM	CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 07:30AM	CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis (AP) (GlobeNewswire) +6.06%
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research) -6.29%
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research) -6.11%
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research) -5.56%
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.16%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research) +7.08%
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research) +13.07%
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research) -17.32%
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research) +11.75%
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research) +28.00%

CalciMedica, Inc. is a clinical-stage biopharmaceutical company, which engages in developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

CEO & DirectorDr. A. Rachel Leheny Ph.D.

Chief Business Officer & Vice Chairman of the BoardMr. Eric W. Roberts

Chief Medical OfficerDr. Sudarshan Hebbar M.D.

M.B.A.Mr. Michael J. Dunn B.A.

Co-Founder and Scientific AdvisorDr. Anjana Rao Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Middleton Fred A	Director	Jun 25 '26	Buy	0.80	248,972	199,999	1,063,272	Jun 29 08:45 AM
Roberts Eric W	CHIEF BUSINESS OFFICER	Sep 18 '25	Buy	3.07	2,500	7,675	84,150	Sep 22 09:35 AM
Roberts Eric W	CHIEF BUSINESS OFFICER	Sep 15 '25	Buy	2.68	3,400	9,105	81,650	Sep 17 09:45 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CALC

CalciMedica Inc

Upgrade your Finviz experience